Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: Results from year 1 of the Voyage Study

Kathleen J. Yost, Rachel E. Carlson, Christine R. Kirt, Emily J. Kirsch, Bonny Kneedler, Jennifer J. Laffin, Jennifer L. St Sauver, Lila J. Finney Rutten, Jessica A. Grimm, Janet E. Olson

Research output: Contribution to journalArticlepeer-review

Abstract

Objective To identify the optimal incentive protocol for maximising participation while managing study costs during the Voyage trial. Design Prospective cohort (Voyage trial) of colorectal cancer (CRC) incidence and mortality outcomes in individuals screened with multitarget stool DNA (mt-sDNA) served as the population. A subset was randomised to receive postage stamps as a pre-consent incentive, or as a post-consent incentive after completion of the consent and questionnaire. Descriptive statistics from year 1 are reported. Results During year 1 of the Voyage trial, a total of 600 258 individuals with mt-sDNA orders received at Exact Sciences Laboratories were randomly selected and invited to participate. Of those, 26 429 (4.4%) opted in, 14 365 of whom (54.3%) consented. The opt-in and consent samples were similar to the target population with respect to sex but differed by geographic residence and age (p<0.001). For the embedded incentive experiment, 2333 were randomised to the pre-incentive arm, while 2342 were randomised to the post-incentive arm. Overall consent rate in the incentive trial was 56.4% (60.9% for the pre-consent incentive arm (1421/2333) vs 52.0% for the post-consent incentive arm (1217/2342), p<0.001). Cost reduction was observed for the pre-consent incentive group, and higher response rates were seen among older versus younger individuals. Conclusions Pre-consent incentive option was associated with a higher participation rate and lower costs and was used for the remainder of study recruitment. CRC incidence and mortality vary with age; thus, adjusting for differential participation by age and region will be important in analyses of Voyage data. Trial registration number NCT04124406.

Original languageEnglish (US)
Article numbere001376
JournalBMJ Open Gastroenterology
Volume11
Issue number1
DOIs
StatePublished - Jul 17 2024
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2024 Author(s) (or their employer(s)).

Keywords

  • COLORECTAL CANCER
  • COLORECTAL CANCER SCREENING
  • STOOL MARKERS

PubMed: MeSH publication types

  • Journal Article
  • Randomized Controlled Trial

Fingerprint

Dive into the research topics of 'Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: Results from year 1 of the Voyage Study'. Together they form a unique fingerprint.

Cite this